The digital therapy platform helps improve grip strength and hand mobility
Spotted: Strokes are the world’s third-leading cause of death and disability combined, and costs more than $721 billion (around €658 billion) annually. The World Stroke Organization reports that the global burden of disability-adjusted life-years lost “increased substantially” from 1990 to 2019 and calls for ‘urgent measures’ to improve post-stroke health outcomes. One method making it easier for providers to see patients sooner is telehealth, which, when combined with robotics technology, brings a range of new methods of care into the home.
The LifeGlov robotic glove brings grip strength and hand mobility rehabilitation services directly to the patient. Created and built by Scottish healthtech company Bioliberty, the LifeGlov reduces travel and wait times for patients while supporting personalisation in care from providers.
The glove is connected to a digital therapy platform to provide exercises tailored to each individual’s capability and strength at the time most convenient for them, and the platform also reminds patients to use their weaker hand and arm in everyday tasks. Healthcare professionals use the platform to monitor rehabilitation programme effectiveness and make quick adjustments to exercises when needed based on a patient’s ability.
Having recently raised £2.2 million (around €2.5 million) in investment, Bioliberty plans to build rehabilitation clinics for a 2024 North America launch. Longer term development will focus on expanding the glove’s capability and the supporting technology in order to provide rehabilitation for other limbs and parts of the body.
Written By: Keely Khoury